Description
A combination of magnolia and phellodendron to relieve symptoms of stress, with skullcap and passionflower, both used in traditional western herbal medicine to relieve symptoms of mild anxiety and nervous tension.
Features:
- Relora® relieves symptoms of stress.
- Relora® relieves symptoms of mild, temporary anxiety in premenopausal women.
- Skullcap and passionflower relieve symptoms of mild anxiety.*
- Skullcap and passionflower are included for nervous system support, relieving nervous tension and restlessness.*
- Passionflower and skullcap are used as a sleep aid, especially when disturbed sleep is due to restlessness and stress.*
|
Each tablet contains: |
|
|
Herbal extracts standardised equiv. to dry: |
|
|
Phellodendron amurense (phellodendron) stem bark |
247.5mg |
|
equiv. to berberine |
250mcg |
|
Magnolia officinalis (magnolia) stem bark |
687.5mg |
|
equiv. to honokiol |
3.75mg |
|
Herbal extracts equiv. to dry: |
|
|
Scutellaria lateriflora (skullcap) herb |
1g |
|
Passiflora incarnata (passionflower) herb top flowering and fruiting |
500mg |
No added dairy, gluten, shellfish, soy protein, yeast.
Vegan and vegetarian friendly.
- If symptoms persist consult your healthcare practitioner.
- Always read the label. Use only as directed.
- If you have any pre-existing conditions, are on any medications, always talk to your health professional before use.
- Some products should be ceased at least two weeks before any elective surgery, please confirm with your health professional.
Prescribing Information:
- RestoraCalm is contraindicated in pregnancy and lactation due to the berberine content of Phellodendron amurense.
- There are no known drug interactions with RestoraCalm; however, Magnolia officinalis bark extract may theoretically potentiate the central depressant effects of other agents that have sedative properties such as alcohol, barbiturates, benzodiazepines and other central nervous system (CNS) depressants.
- There is preliminary evidence that berberine, a constituent of Phellodendron amurense, may inhibit cytochrome P450 3A4 (CYP3A4) enzymes; however, this interaction is yet to be reported in humans.
- Skullcap could theoretically potentiate the effects of CNS depressants; concomitant usage is not recommended.
- Skullcap inhibits the CYP3A4 enzyme, so caution must be taken for patients taking drugs metabolized by this pathway.
- Concomitant use of passionflower with alcohol or pharmaceutical sedatives may have an additive effect.
TGA Listed product with Aust L .
Download TGA Public Summary for TGA published information including excipients, which are listed under 'Other Ingredients'.
Download TGA Public Summary for TGA published information including excipients, which are listed under 'Other Ingredients'.